We have 3 of 61 papers
We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.
Not the right person? Other researchers publish under this name.
BACKGROUND Whether participants with different cardiometabolic renal health profiles would derive comparable cognitive benefits from intensive blood pressure (BP)-lowering treatment remains underexplored. METHODS This post hoc analysis of the Systolic Blood Pressure Intervention Trial (SPRINT) derived a cardiometabol...
Low-grade albuminuria is highlighted as a key preventive window for cardiorenal outcomes requiring both aspects of modifiable risk factors, and the cardiovascular benefits of metabolic improvement in established albuminuria.
We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.
